CHHE (China Health Industries Holdings) Interest Expense : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China Health Industries Holdings's interest expense for the three months ended in Mar. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China Health Industries Holdings's Operating Income for the three months ended in Mar. 2024 was $ -0.14 Mil. China Health Industries Holdings's Interest Expense for the three months ended in Mar. 2024 was $ 0.00 Mil. China Health Industries Holdings has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

China Health Industries Holdings Interest Expense Historical Data

The historical data trend for China Health Industries Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings Interest Expense Chart

China Health Industries Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

China Health Industries Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

China Health Industries Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

China Health Industries Holdings (OTCPK:CHHE) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Health Industries Holdings's Interest Expense for the three months ended in Mar. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-0.14 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

China Health Industries Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

China Health Industries Holdings had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

China Health Industries Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028

Website

http://www.chinahealthindustries.com

China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.

Executives

Sun Xin	director, 10 percent owner, officer: CEO, CFO and Treasurer	NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing	director, officer: Secretary	2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson	director	16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster	director	402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn	director, officer: COO	422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee	10 percent owner	3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems	10 percent owner, officer: President, CEO, CFO and, other: Secretary	1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings Headlines

No Headlines